Skip to main content

Table 4 RDS-adjusted point estimates and confidence intervals of health outcomes and service utilization among people who inject drugs in Mozambique, 2013–2014

From: High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique

 

Maputo (n = 353)

Nampula/Nacala (n = 139)

na

Crude

Adj b %

95% CI

na

Crude

Adj b %

95% CI

Has access to new, unused syringes or needles

315

89.2

89.6

85.4–93.6

110

79.7

78.9

69.6–87.2

 Missing

0

 

1

 

Had contact with a peer educator, last 12 months

40

11.4

9.5

5.3–13.3

62

44.6

40.8

31.5–52.0

 Missing

1

 

0

 

Received free condoms, last 12 months

100

28.6

26.8

21.0–33.7

88

63.3

60.0

49.2–71.3

 Missing

3

 

0

 

Ever received treatment for overdose, drug substitution therapy or detoxification, lifetime

16

4.5

2.5

1.2–4.1

37

26.6

23.7

16.4–31.9

Ever in a rehabilitation or a self-help group, lifetimec

12

3.4

2.5

0.9–4.8

26

18.7

14.3

7.8–22.1

Ever incarcerated, lifetime

264

74.8

72.2

66.4–78.0

64

46.0

42.6

29.9–52.9

Previous HIV test, lifetime

254

72.0

68.4

61.1–75.4

80

57.6

59.0

46.4–68.6

Previous HIV test, last 12 months

80

22.9

24.6

18.9–30.0

35

25.2

21.9

12.7–31.4

 Missing

4

0

 

Ever heard of Hepatitis B or C

138

39.1

34.7

28.3–41.4

73

52.5

52.1

40.8–617

Has HIV

179

56.1

50.1

40.1–59.0

25

19.8

19.9

10.9–29.2

 Did not consent

34

   

13

   

Screen positive for Hepatitis B surface antigen

107

30.5

32.1

25.2–38.5

57

41.0

36.4

22.6–49.8

 Did not consent

2

   

0

   

Hepatitis C antibodies

148

47.6

44.6

33.4–53.9

15

11.1

7.0

2.0–12.5

 Did not consent

42

   

4

   

Has HIV & HBV surface antigen

49

15.4

14.9

9.1–19.5

10

7.9

8.3

2.4–14.9

 Did not consent

35

   

13

   

Has HIV & HCV antibodies

116

38.7

36.1

26.4–45.8

8

6.5

4.1

0.6–8.4

 Did not consent

53

   

15

   

Ever tested positive for HIV prior to the survey

123

34.9

29.0

22.1–44.3

10

7.2

5.8

1.7–11.2

 Missing

1

   

1

   

Had a self-reported sore or ulcer in the genital region, last 12 months

30

8.5

8.0

4.7–11.7

35

25.2

28.6

19.1–37.9

  1. a Sample includes seeds; no missing responses unless specified
  2. b Adjusted estimates and 95% confidence intervals (CI) produced with RDSAT 7.1
  3. c Includes self-help groups, outpatient counseling, drug substitution therapy, detoxification program or rehabilitation